Screening Tool to Identify Patients with Advanced Aortic Valve Stenosis
- PMID: 35956007
- PMCID: PMC9369431
- DOI: 10.3390/jcm11154386
Screening Tool to Identify Patients with Advanced Aortic Valve Stenosis
Abstract
(1) Background: The clinical burden of aortic stenosis (AS) remains high in Western countries. Yet, there are no screening algorithms for this condition. We developed a risk prediction model to guide targeted screening for patients with AS. (2) Methods: We performed a cross-sectional analysis of all echocardiographic studies performed between 2013 and 2018 at a tertiary academic care center. We included reports of unique patients aged from 40 to 95 years. A logistic regression model was fitted for the risk of moderate and severe AS, with readily available demographics and comorbidity variables. Model performance was assessed by the C-index, and its calibration was judged by a calibration plot. (3) Results: Among the 38,788 reports yielded by inclusion criteria, there were 4200 (10.8%) patients with ≥moderate AS. The multivariable model demonstrated multiple variables to be associated with AS, including age, male gender, Caucasian race, Body Mass Index ≥ 30, and cardiovascular comorbidities and medications. C-statistics of the model was 0.77 and was well calibrated according to the calibration plot. An integer point system was developed to calculate the predicted risk of ≥moderate AS, which ranged from 0.0002 to 0.7711. The lower 20% of risk was approximately 0.15 (corresponds to a score of 252), while the upper 20% of risk was about 0.60 (corresponds to a score of 332 points). (4) Conclusions: We developed a risk prediction model to predict patients' risk of having ≥moderate AS based on demographic and clinical variables from a large population cohort. This tool may guide targeted screening for patients with advanced AS in the general population.
Keywords: aortic; mortality; prediction; risk; stenosis.
Conflict of interest statement
Geirsson receives a consulting fee for being a member of the Medtronic Strategic Surgical Advisory Board. Medtronic produces valve products for valve replacement and repairs. Krane is a physician proctor and a member of the medical advisory board for JOMDD, a physician proctor for Peter Duschek, and has received speakers’ honoraria from Medtronic and Terumo. The remaining authors have nothing to disclose.
Figures
References
-
- Osnabrugge R.L., Mylotte D., Head S.J., Van Mieghem N.M., Nkomo V.T., LeReun C.M., Bogers A.J., Piazza N., Kappetein A.P. Aortic stenosis in the elderly: Disease prevalence and number of candidates for transcatheter aortic valve replacement: A meta-analysis and modeling study. J. Am. Coll. Cardiol. 2013;62:1002–1012. doi: 10.1016/j.jacc.2013.05.015. - DOI - PubMed
-
- Tang L., Gössl M., Ahmed A., Garberich R., Bradley S.M., Niikura H., Witt D., Pedersen W.R., Bae R., Lesser J.R., et al. Contemporary Reasons and Clinical Outcomes for Patients with Severe, Symptomatic Aortic Stenosis Not Undergoing Aortic Valve Replacement. Circ. Cardiovasc. Interv. 2018;11:e007220. doi: 10.1161/CIRCINTERVENTIONS.118.007220. - DOI - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
